Prematurity Prevention: Increasing the Utilization of 17-Hydroxyprogesterone and Low Dose Aspirin Among Eligible Pregnant Patients in Connecticut
Location: Connecticut Hospital Association, 110 Barnes Road, Wallingford, CT 06492
There is no fee for this event.
Premature birth is a complex issue, for which many of the causes are still being researched. However, there are a handful of evidence-based interventions that have proven beneficial for a great number of eligible patients. Please join CHA’s Connecticut Perinatal Quality Collaborative and the March of Dimes to engage with other prenatal care providers, women’s healthcare advocates, support systems, administrators, and policy makers across Connecticut to work collaboratively to increase identification of women at risk for preeclampsia and repeat pre-term birth, and collectively inform efforts aimed at the elimination of barriers to access these treatments.
Jay Iams, MD, Emeritus Professor of Obstetrics and Gynecology, Ohio State University, Wexner Medical Center, Obstetrical Lead, Ohio Perinatal Quality Collaborative, Principal Investigator, OSU NICHD Maternal Fetal Medicine and Nullipara Research Networks, will present the keynote presentation at this conference.
17-hydroxyprogesterone (17P) and low dose aspirin are among the eight interventions promoted nationally by the March of Dimes, with an aim to reduce the U.S. pre-term birth rate to 8.1% by 2020 and 5.5% by 2030.
Lunch will be provided; registration and lunch begin at 12:30 p.m.
There are errors in your form submission, please see below for details.
Registration for this event is now closed.